Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose

PURPOSE: Yttrium-90 (90Y) radioembolization with an escalated dose has been shown to improve clinical outcomes compared with standard dose radioembolization, but there are few data on the local control of primary liver tumors. We reported the clinical outcomes of patients with unresectable primary l...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Re-I, Bommireddy, Anirudh, Fraum, Tyler J., Ludwig, Daniel R., Huang, Yi, Zoberi, Jacqueline E., Garcia-Ramirez, Jose L., Maughan, Nichole M., Chapman, William, Korenblat, Kevin, Henke, Lauren E., Kim, Hyun, Badiyan, Shahed N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260102/
https://www.ncbi.nlm.nih.gov/pubmed/35814852
http://dx.doi.org/10.1016/j.adro.2022.100948

Ejemplares similares

Ejemplares similares